Literature DB >> 16709814

Abrogation of functional selectin-ligand expression reduces migration of pathogenic CD8+ T cells into heart.

Yi Hong Cai1, Angeles Alvarez, Pilar Alcaide, Paurene Duramad, Yaw-Chin Lim, Petr Jarolim, John B Lowe, Francis W Luscinskas, Andrew H Lichtman.   

Abstract

CD8+ T cells are involved in autoimmune and infectious myocarditis and cardiac allograft rejection. The role of selectins in cardiac recruitment of CD8+ T cells is not understood. In this study, the contribution of T cell selectin ligands to effector CD8+ T cell recruitment into the heart was examined using a model of myocarditis, which depends on transfer of OVA peptide-specific CD8+ T cells (OT-I) into mice (CMy-mOva) that express OVA in the heart. alpha-(1,3)-Fucosyltransferase (FucT)-VII-deficient OT-I cells displayed over a 95% reduction in their ability to interact with P-selectin under flow conditions in vitro, compared with wild-type OT-I cells. Interaction of FucT-VII-deficient OT-I cells with E-selectin was reduced approximately 50%. FucT-VII-deficient OT-I cells were also less efficiently recruited into a dermal site of Ag and adjuvant injection. Significantly, FucT-VII-deficient OT-I cells were also impaired in their ability to migrate into CMy-mOva hearts, compared with wild-type OT-I cells. Transfer of FucT-VII-deficient T cells caused less severe early myocarditis and myocyte damage than transfer of wild-type T cells. Combined FucT-IV/VII-deficient OT-I cells displayed a more profound reduction in E-selectin interactions in vitro compared with FucT-VII-deficient T cells, and the FucT-IV/VII-deficient T cells also showed less early recruitment and pathogenicity in the CMy-mOva myocarditis model. These results identify a prominent role for selectin ligands in contributing to effector CD8+ T cell recruitment into the myocardium and indicate that selectin-dependent T cell recruitment is relevant to other tissues besides the skin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16709814     DOI: 10.4049/jimmunol.176.11.6568

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Endogenous migration modulators as parent compounds for the development of novel cardiovascular and anti-inflammatory drugs.

Authors:  Wolfgang Poller; Madlen Rother; Carsten Skurk; Carmen Scheibenbogen
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  E-Selectin Mediates Immune Cell Trafficking in Corneal Transplantation.

Authors:  Thomas H Dohlman; Antonio Di Zazzo; Masahiro Omoto; Jing Hua; Julia Ding; Pedram Hamrah; Sunil K Chauhan; Reza Dana
Journal:  Transplantation       Date:  2016-04       Impact factor: 4.939

3.  Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo.

Authors:  N M Valenzuela; L Hong; X-Da Shen; F Gao; S H Young; E Rozengurt; J W Kupiec-Weglinski; M C Fishbein; E F Reed
Journal:  Am J Transplant       Date:  2012-12-27       Impact factor: 8.086

Review 4.  Leukocyte transmigration across endothelial and extracellular matrix protein barriers in liver ischemia/reperfusion injury.

Authors:  Ana J Coito
Journal:  Curr Opin Organ Transplant       Date:  2011-02       Impact factor: 2.640

Review 5.  Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans.

Authors:  James S Young; Christine McIntosh; Maria-Luisa Alegre; Anita S Chong
Journal:  Transplantation       Date:  2017-11       Impact factor: 4.939

6.  Naïve T cells re-distribute to the lungs of selectin ligand deficient mice.

Authors:  John R Harp; Thandi M Onami
Journal:  PLoS One       Date:  2010-06-04       Impact factor: 3.240

7.  Alterations in human breast cancer adhesion-motility in response to changes in cell surface glycoproteins displaying alpha-L-fucose moieties.

Authors:  Kun Yuan; Dennis Kucik; Raj K Singh; Catherine M Listinsky; Jay J Listinsky; Gene P Siegal
Journal:  Int J Oncol       Date:  2008-04       Impact factor: 5.650

8.  Lack of functional selectin ligand interactions compromises long term tumor protection by CD8+ T cells.

Authors:  Felicity C Stark; Komal Gurnani; Subash Sad; Lakshmi Krishnan
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

9.  A new in vitro model of polymyositis reveals CD8+ T cell invasion into muscle cells and its cytotoxic role.

Authors:  Mari Kamiya; Fumitaka Mizoguchi; Akito Takamura; Naoki Kimura; Kimito Kawahata; Hitoshi Kohsaka
Journal:  Rheumatology (Oxford)       Date:  2020-01-01       Impact factor: 7.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.